KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Accumulated Expenses (2016 - 2026)

Idexx Laboratories has reported Accumulated Expenses over the past 17 years, most recently at $530.1 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 5.58% year-over-year to $530.1 million; the TTM value through Dec 2025 reached $530.1 million, up 5.58%, while the annual FY2025 figure was $530.1 million, 5.58% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $530.1 million at Idexx Laboratories, up from $488.9 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $541.1 million in Q2 2024 and troughed at $366.9 million in Q1 2021.
  • A 5-year average of $447.3 million and a median of $432.4 million in 2021 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: surged 48.43% in 2021 and later decreased 22.94% in 2025.
  • Year by year, Accumulated Expenses stood at $458.9 million in 2021, then decreased by 5.5% to $433.7 million in 2022, then rose by 10.39% to $478.7 million in 2023, then grew by 4.89% to $502.1 million in 2024, then rose by 5.58% to $530.1 million in 2025.
  • Business Quant data shows Accumulated Expenses for IDXX at $530.1 million in Q4 2025, $488.9 million in Q3 2025, and $417.0 million in Q2 2025.